From: Galectin-1 as a predictive biomarker in ovarian cancer
Characteristics | N=84 | |
---|---|---|
No of patients | %age | |
Age (years) | ||
 Mean age |  | 46.66±15.42 |
 Median |  | 50 |
 Range |  | 14-70 |
 >45 | 48 | 57.1 |
 ≤45 | 36 | 42.8 |
Menopause | ||
 Pre  Post | 35 49 | 41.6 58.3 |
FIGO Stage | ||
 I-II  III-IV | 27 46 | 32.1 54.7 |
Lymph nodes involved | ||
 Yes  No | 28 56 | 33.3 66.6 |
Metastasis | ||
 No  Yes | 41 43 | 48.8 51.1 |
Parity | ||
 0  >1 | 20 64 | 23.8 76.1 |
Menstruation | ||
 Normal  Amenorrhea  Dysmenorrhea  Polymenorrhea | 50 4 28 2 | 59.5 4.7 33.3 2.3 |